Sanofi (SNY) Current Taxes (2015 - 2025)

Sanofi has disclosed Current Taxes across 11 years of filings, most recently posting $874.2 million for Q4 2025.

• Current Taxes for Q4 2025 came in at $874.2 million, up 17.37% year-over-year; the trailing twelve-month figure through Dec 2025 was $874.2 million (up 17.37% YoY), and the FY2025 annual result was $874.2 million, up 17.37% from the prior year.
• Current Taxes came in at $874.2 million for Q4 2025 at Sanofi, up from $819.5 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $874.2 million in Q4 2025 to a low of $142.1 million in Q2 2024.
• The 5-year median for Current Taxes is $614.0 million (2023), against an average of $575.3 million.
• Across the five-year window, Current Taxes plunged 65.37% in 2024 and soared 476.53% in 2025, its largest moves.
• Sanofi's Current Taxes stood at $353.5 million in 2021, then surged by 65.67% to $585.6 million in 2022, then grew by 9.68% to $642.3 million in 2023, then grew by 15.95% to $744.8 million in 2024, then grew by 17.37% to $874.2 million in 2025.
• The last three Current Taxes figures came in at $874.2 million (Q4 2025), $819.5 million (Q2 2025), and $744.8 million (Q4 2024), per Business Quant data.